At this moment of political change in Europe, EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences. A Competitiveness Strategy for European Life Sciences and greater policy coherence would help Europe regain its position as the premier location for scientific research, skills and private investment.

Learn more here.

With €50 billion invested in R&D in Europe in 2023, the pharmaceutical industry is the sector that invests the greatest percentage of its revenue in R&D. However, last year, China surpassed Europe as a region for launching new active substances globally. After losing its crown to the US as the top innovation region in the world in 2000, Europe is now in third place.

Read the full report here.

The 8th IHI call for proposals is now live! Submit your short proposal before 10 October for the following topics: cardiovascular disease, osteoarthritis, regulatory sandboxes, and patient-centred endpoints.

Learn more here.

Fresh after the European elections, Nathalie Moll joined an expert panel dissecting the significance of the results for the future of the EU’s health policy.

“I have this vision of Europe in 50 years’ time being a great museum that everybody comes to visit to see how things used to be, and that's not what I want. I want us to be like we were during Covid, the producers of innovation for the rest of the world and the open market, the exporters and the ones who take care not only of our citizens but of the rest of the world - and we can only do that if we have the innovation to start with.” Nathalie Moll told the audience.

Watch the recording here.